Cell Culture Company

Executive Summary

Cell Culture Company is a privately-held contract development and manufacturing organization (CDMO) headquartered in Shoreview, Minnesota, with over 30 years of experience in cell culture technologies. Founded in 1994, the company specializes in providing critical services for biotech and pharmaceutical clients, including cell banking, protein production, and proprietary hollow-fiber perfusion systems. Its expertise enables the development and manufacturing of advanced therapies and biologics, positioning it as a key partner in the rapidly growing cell therapy and biologics market. As a private entity, Cell Culture Company maintains a low public profile but plays a vital role in the supply chain for innovative treatments. The company's long-standing presence and specialized focus on cell culture give it a competitive edge in supporting clients from early-stage development to commercial production. With the increasing demand for cell-based therapeutics and biologics, Cell Culture Company is well-positioned to capitalize on industry trends, though its private status limits visibility into financial performance and growth metrics.

Upcoming Catalysts (preview)

• Q2 2027New facility expansion to increase manufacturing capacity65% success
• H2 2026Strategic partnership with a major biotech company for cell therapy production60% success
• Q4 2026FDA approval of a client's biologic using Cell Culture Company's perfusion technology50% success